Lanean...
Approval gap of pharmacogenomic biomarkers and in vitro companion diagnostics between the United States and Japan
WHAT IS KNOWN AND OBJECTIVES: In vitro companion diagnostic devices (CDx) provide information on pharmacogenomic biomarkers (PGBMs) to enable the safe and effective use of targeted agents for personalized therapy. These devices require specific regulations that strike a balance between scientific ev...
Gorde:
| Argitaratua izan da: | J Clin Pharm Ther |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BlackWell Publishing Ltd
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4237189/ https://ncbi.nlm.nih.gov/pubmed/24405254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcpt.12129 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|